Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a\Arf

Zhongqiu Zhang, Yian Wang, Laura E. Lantry, Elizabeth Kastens, Gongjie Liu, Andrew D. Hamilton, Said M. Sebti, Ronald A. Lubet, Ming You

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a\Arf'. Together they form a unique fingerprint.

Medicine & Life Sciences